Doctronic reports new AI analysis reveals GLP-1 medications may cause underreported symptoms like menstrual irregularities ...

GLP-1 drugs are reshaping the lives of many, but such treatments can come with a side order of stigma, even shame ...

Why the Compliance Answer You’re Getting May Not Be the Answer You Need- If your company offers health benefits, someone has ...

AI-enabled research shifts decision-making to late-night online moments; brands must engage when intent crystallizes and ...

Who needs more than two employees when artificial intelligence can do so many corporate tasks? It’s super efficient — and a ...

Q3 reiterated FY 2026 gross margin range “62% to 63%” (CFO Sandercock), consistent with Q2’s updated FY 2026 gross margin range.

AI is everywhere, all at once. How does that make you feel? It was mid-March 2020, and none of us knew what to expect. All ...

At the AXS26 Summit, Wheel’s Chris Moose argued that pharmaceutical companies must abandon outdated, prescription-focused engagement models and meet patients earlier in their decision-making process.

Most readers start looking for information with AI. Publishers need a new audience map to meet them where they are. For ...

ChatGPT Image 2.0 suggests that AI image generation is evolving into visual reasoning and verifiable AI, with implications ...

For years, the only way to take a GLP-1 weight-loss drug was to inject it. That changed in late 2025, when the FDA cleared a 25 mg oral semaglutide tablet, sold under the Wegovy brand, making it the ...

Good afternoon, everyone, and welcome to our first quarter of 2026 earnings call. Bob Bradway will lead the call today and be followed by a broader review of our performance by Murdo Gordon, Jay ...